DK0538134T3 - Monofluorerede derivater af N-propargyl-1-aminoindan og deres anvendelse som inhibitorer for monoaminoxidase - Google Patents
Monofluorerede derivater af N-propargyl-1-aminoindan og deres anvendelse som inhibitorer for monoaminoxidaseInfo
- Publication number
- DK0538134T3 DK0538134T3 DK92402821.0T DK92402821T DK0538134T3 DK 0538134 T3 DK0538134 T3 DK 0538134T3 DK 92402821 T DK92402821 T DK 92402821T DK 0538134 T3 DK0538134 T3 DK 0538134T3
- Authority
- DK
- Denmark
- Prior art keywords
- propargyl
- monoamine oxidase
- inhibitors
- aminoindan
- monofluorinated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL99759A IL99759A (en) | 1991-10-16 | 1991-10-16 | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0538134T3 true DK0538134T3 (da) | 1997-04-01 |
Family
ID=11062970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92402821.0T DK0538134T3 (da) | 1991-10-16 | 1992-10-15 | Monofluorerede derivater af N-propargyl-1-aminoindan og deres anvendelse som inhibitorer for monoaminoxidase |
Country Status (16)
Country | Link |
---|---|
US (1) | US5486541A (zh) |
EP (1) | EP0538134B1 (zh) |
JP (1) | JP3247165B2 (zh) |
CN (1) | CN1038928C (zh) |
AT (1) | ATE149999T1 (zh) |
AU (1) | AU649565B2 (zh) |
CA (1) | CA2079968C (zh) |
DE (1) | DE69218101T2 (zh) |
DK (1) | DK0538134T3 (zh) |
ES (1) | ES2101063T3 (zh) |
FI (1) | FI113262B (zh) |
GR (1) | GR3023556T3 (zh) |
HU (1) | HU217589B (zh) |
IL (2) | IL112819A (zh) |
NZ (1) | NZ244616A (zh) |
ZA (1) | ZA927570B (zh) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744500A (en) * | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
EP0712387B1 (en) * | 1993-08-06 | 1999-12-08 | PHARMACIA & UPJOHN COMPANY | 2-aminoindans as selective dopamine d3 ligands |
IL111240A (en) * | 1993-10-18 | 2001-10-31 | Teva Pharma | Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them |
US5877218A (en) | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
ATE346598T1 (de) * | 1994-01-10 | 2006-12-15 | Teva Pharma | 1-aminoindanderivate und zusammensetzungen hiervon |
IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
IL118836A (en) * | 1996-07-11 | 2001-01-11 | Teva Pharma | Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan |
US6191166B1 (en) * | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
ATE377585T1 (de) | 1996-12-18 | 2007-11-15 | Teva Pharma | Aminoindanderivate |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
US6635632B1 (en) * | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
GB9715082D0 (en) * | 1997-07-17 | 1997-09-24 | Scherer Ltd R P | Treatment of attention deficit hyperactivity disorder and narcolepsy |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6492426B1 (en) | 1999-10-27 | 2002-12-10 | Teva Pharmaceutical Industries, Ltd. | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
US6949575B2 (en) | 2000-05-04 | 2005-09-27 | Pfizer Inc. | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
TWI290549B (en) * | 2000-06-02 | 2007-12-01 | Astrazeneca Ab | Process for the preparation of cyclopropyl carboxylic acid ester and derivatives |
AU2001296703A1 (en) * | 2000-10-06 | 2002-04-15 | Xenoport, Inc. | Bile acid prodrugs of l-dopa and their use in the sustained treatment of parkinsonism |
US6956129B2 (en) | 2001-02-16 | 2005-10-18 | Bayer Aktiengesellschaft | Polyhalogen-substituted cinnamic acids and cinnamic acid derivatives and a process for the preparation of polyhalogen-substituted cinnamic acids and cinnamic acid derivatives |
US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
DK1567152T3 (da) * | 2002-11-15 | 2013-10-07 | Teva Pharma | Anvendelse af rasagilin med riluzol til behandling af amyotroph lateral sklerose |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
US8097608B2 (en) | 2003-11-25 | 2012-01-17 | Technion Research And Development Foundation Ltd. | Methods for treatment of cardiovascular disorders and diseases |
EP1686973A4 (en) * | 2003-11-25 | 2009-03-25 | Technion Res & Dev Foundation | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES |
US20080090915A1 (en) * | 2003-11-25 | 2008-04-17 | Technion Research And Development Foundation Ltd. | Method for preventing or attenuating anthracycline-induced cardiotoxicity |
US20060018957A1 (en) * | 2004-07-26 | 2006-01-26 | Lerner E I | Pharmaceutical dosage forms including rasagiline |
US20060025446A1 (en) * | 2004-07-27 | 2006-02-02 | Jeffrey Sterling | Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders |
RS52867B (en) * | 2005-02-17 | 2013-12-31 | Teva Pharmaceutical Industries Ltd. | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS |
US20100167983A1 (en) * | 2007-10-22 | 2010-07-01 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
US7815942B2 (en) | 2005-02-23 | 2010-10-19 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
US7649115B2 (en) * | 2005-06-02 | 2010-01-19 | Jenrin Discovery, Inc. | MAO-B inhibitors useful for treating obesity |
US8263655B2 (en) | 2005-10-06 | 2012-09-11 | Technion Research And Development Foundation Ltd | Methods for treatment of renal failure |
EP1954667B1 (en) | 2005-11-17 | 2017-02-08 | Teva Pharmaceutical Industries Ltd | Methods for isolating propargylated aminoindans |
US7572834B1 (en) | 2005-12-06 | 2009-08-11 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations and processes for their preparation |
JP2009518433A (ja) | 2005-12-09 | 2009-05-07 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム | 神経保護用の低用量ラドスチギルの使用 |
WO2007098264A2 (en) | 2006-02-21 | 2007-08-30 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of multiple system atrophy |
TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
MX2008012781A (es) * | 2006-04-03 | 2008-10-14 | Teva Pharma | Uso de rasagilina para el tratamiento de sindrome de piernas inquietas. |
EP1892233A1 (de) * | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
MX2009006252A (es) * | 2006-12-14 | 2009-10-13 | Teva Pharma | Sal de tanato de rasagilina. |
KR101459744B1 (ko) * | 2006-12-14 | 2014-11-20 | 테바 파마슈티컬 인더스트리즈 리미티드 | 결정성 고형 라사길린 염기 |
EP1987816A1 (de) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff |
AU2008296908B2 (en) * | 2007-09-05 | 2014-01-09 | Teva Pharmaceutical Industries, Ltd. | Method of treating glaucoma using rasagiline |
US8188149B2 (en) * | 2007-09-17 | 2012-05-29 | Teva Pharmaceutical Industries, Ltd. | Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss |
EP2053033A1 (en) | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
WO2009089049A1 (en) * | 2008-01-11 | 2009-07-16 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations, their preparation and use |
JP2011524353A (ja) * | 2008-06-10 | 2011-09-01 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリン軟ゼラチンカプセル |
CN103893160A (zh) * | 2008-06-13 | 2014-07-02 | 泰华制药工业有限公司 | 雷沙吉兰用于改善帕金森氏症 |
JP2011525489A (ja) * | 2008-06-19 | 2011-09-22 | テバ ファーマシューティカル インダストリーズ リミティド | ラサリジン塩基の精製方法 |
MX2010013875A (es) | 2008-06-19 | 2011-01-20 | Teva Pharma | Proceso para preparar y secar base de rasagilina solida. |
EP2367782B1 (en) * | 2008-12-22 | 2013-02-13 | KRKA, D.D., Novo Mesto | Process for preparation of ivabradine |
US20100189791A1 (en) * | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline malate formulation |
DK2451771T3 (da) | 2009-07-09 | 2014-09-08 | Ratiopharm Gmbh | Salte af rasagilin og farmaceutiske fremstillingsmåder heraf |
AU2010341499A1 (en) * | 2009-12-22 | 2012-08-09 | Teva Pharmaceutical Industries Ltd. | 3-keto-N-propargyl-1-aminoindan |
US9943489B2 (en) | 2010-02-03 | 2018-04-17 | Pharmatwob Ltd. | Extended release formulations of rasagiline and uses thereof |
EP2598136A4 (en) | 2010-07-27 | 2015-03-25 | Teva Pharma | DISPERSIONS OF RASAGILINE CITRATE |
AU2011282720B2 (en) | 2010-07-27 | 2016-12-22 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of olfactory dysfunction |
CA2851276A1 (en) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | R(+)-n-formyl-propargyl-aminoindan |
BR112014008552A2 (pt) | 2011-10-10 | 2017-04-18 | Teva Pharma | r(+)-n-metil-propargilaminoindano |
MX2015002062A (es) | 2012-08-17 | 2015-06-05 | Teva Pharma | Formulaciones parenterales de rasagilina. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3201470A (en) * | 1965-08-17 | Chsx c cech | ||
US3253037A (en) * | 1962-06-19 | 1966-05-24 | Ciba Geigy Corp | N-2-alkynyl-amino-benzocylo-alkanes |
GB1187017A (en) * | 1966-07-16 | 1970-04-08 | Aspro Nicholas Ltd | Substituted 1-Amino Indanes and Tetrahydronaphthalens |
GB1033686A (en) * | 1965-05-10 | 1966-06-22 | Maximilian Heller | Improvements in convertible double bed settees |
HU207282B (en) * | 1984-05-31 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them |
HU208484B (en) * | 1988-08-17 | 1993-11-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia |
IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
-
1991
- 1991-10-16 IL IL11281991A patent/IL112819A/en not_active IP Right Cessation
- 1991-10-16 IL IL99759A patent/IL99759A/xx not_active IP Right Cessation
-
1992
- 1992-09-30 AU AU26063/92A patent/AU649565B2/en not_active Ceased
- 1992-10-01 ZA ZA927570A patent/ZA927570B/xx unknown
- 1992-10-02 FI FI924458A patent/FI113262B/fi active
- 1992-10-05 NZ NZ244616A patent/NZ244616A/en not_active IP Right Cessation
- 1992-10-06 CA CA002079968A patent/CA2079968C/en not_active Expired - Fee Related
- 1992-10-06 HU HU9203162A patent/HU217589B/hu not_active IP Right Cessation
- 1992-10-14 CN CN92113070A patent/CN1038928C/zh not_active Expired - Fee Related
- 1992-10-15 ES ES92402821T patent/ES2101063T3/es not_active Expired - Lifetime
- 1992-10-15 JP JP27731492A patent/JP3247165B2/ja not_active Expired - Fee Related
- 1992-10-15 DK DK92402821.0T patent/DK0538134T3/da active
- 1992-10-15 AT AT92402821T patent/ATE149999T1/de not_active IP Right Cessation
- 1992-10-15 EP EP92402821A patent/EP0538134B1/en not_active Expired - Lifetime
- 1992-10-15 DE DE69218101T patent/DE69218101T2/de not_active Expired - Fee Related
-
1994
- 1994-09-22 US US08/310,480 patent/US5486541A/en not_active Expired - Lifetime
-
1997
- 1997-05-26 GR GR970401207T patent/GR3023556T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI924458A (fi) | 1993-04-17 |
AU649565B2 (en) | 1994-05-26 |
IL99759A (en) | 1997-06-10 |
EP0538134A3 (en) | 1993-06-16 |
FI924458A0 (fi) | 1992-10-02 |
HU9203162D0 (en) | 1992-12-28 |
CA2079968A1 (en) | 1993-04-17 |
FI113262B (fi) | 2004-03-31 |
EP0538134B1 (en) | 1997-03-12 |
JP3247165B2 (ja) | 2002-01-15 |
US5486541A (en) | 1996-01-23 |
CN1038928C (zh) | 1998-07-01 |
DE69218101D1 (de) | 1997-04-17 |
ZA927570B (en) | 1993-04-14 |
CN1073427A (zh) | 1993-06-23 |
HUT67218A (en) | 1995-03-28 |
EP0538134A2 (en) | 1993-04-21 |
IL99759A0 (en) | 1992-08-18 |
ATE149999T1 (de) | 1997-03-15 |
CA2079968C (en) | 2004-12-21 |
HU217589B (hu) | 2000-02-28 |
IL112819A (en) | 2001-11-25 |
DE69218101T2 (de) | 1997-09-25 |
ES2101063T3 (es) | 1997-07-01 |
JPH05262701A (ja) | 1993-10-12 |
GR3023556T3 (en) | 1997-08-29 |
NZ244616A (en) | 1995-04-27 |
AU2606392A (en) | 1993-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0538134T3 (da) | Monofluorerede derivater af N-propargyl-1-aminoindan og deres anvendelse som inhibitorer for monoaminoxidase | |
NO992492L (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
NO990667D0 (no) | Depeptid-benzamidin som kinogenase-inhibitor | |
DK1222192T3 (da) | Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
DK130584D0 (da) | N-(2-nitrophenyl)-4-amino-pyrimidin-derivater samt deres fremstilling og anvendelse som mikrobicider | |
NO996208D0 (no) | Nye 2-(iminometyl)amino- fenylderivater, fremstilling og blandinger derav, samt anvendelse som legemiddel | |
NO934628L (no) | Retrovirus-protease-inhibitorer | |
DK0699180T3 (da) | Bicykliske amidderivater og anvendelse af disse som muskelafspændende midler | |
DK0623121T3 (da) | Fremstilling af N-acetylneuraminsyrederivater | |
DK412782A (da) | Substituerede phenylurinstofderivater, deres fremstilling og mellemprodukter hertil samt deres anvendelse som herbicider | |
DK0446802T3 (da) | Iminothiazoliner, deres fremstilling og anvendelse som herbicider samt mellemprodukter til deres fremstilling | |
DK0861250T3 (da) | Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase | |
ES2185196T3 (es) | Un procedimiento para la preparacion de tetraazamacrociclos. | |
DK0559774T3 (da) | Individuelle stereoisomerer af 7-/3-(1-aminoalkyl)-1-pyrrolidinal/-quinoloner og naphthyridoner som antibakterielle midler | |
DK4287D0 (da) | Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler | |
DK0736009T3 (da) | N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter | |
DK0671388T3 (da) | (Pyrrolidinyl)phenylcarbamater og mellemproduktforbindelser, fremgangsmåder til deres fremstilling og deres anvendelse som | |
DK437287A (da) | 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater | |
DK1000067T3 (da) | Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne | |
DK34888D0 (da) | Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer | |
DK0423445T3 (da) | 12-Alkyl-23-imino- og 13-halogen-23-imino-derivater af LL-F28249-forbindelser og deres anvendelse som endo- og ektoparasiticide, insekticide, akaricide og nematodicide midler | |
DK0924198T3 (da) | 3-mercapto-2-alkyl-alkan-1-oler og anvendelse deraf som duft- og aromastoffer | |
TR199901092T2 (xx) | Oksazolin türevlerinin hazırlanması için işlem ve ara maddeler. | |
DK0489547T3 (da) | Fremgangsmåde til fremstilling af en 3-alkyleret indol, mellemprodukter og en fremgangsmåde til fremstilling af et derivat |